• SAFETY DATA SHEET

Enclomiphene for UK Research

Enclomifene, also known as Enclomiphene, is the (E)-enantiomer of clomiphene citrate, a selective estrogen receptor modulator (SERM) specifically developed to stimulate endogenous T-production in cases of secondary hypogonadism. Unlike traditional T-replacement therapies, which suppress the hypothalamic-pituitary-gonadal (HPG) axis, it works by blocking estrogen receptors in the hypothalamus.

Key findings from preclinical and clinical studies indicate that enclomiphene may:

• Enhance mitochondrial biogenesis and oxidative metabolism in skeletal muscle tissue
• Increase total energy expenditure and attenuate adipose accumulation under sedentary conditions
• Improve exercise tolerance and endurance-related parameters in animal models, independent of physical training
• Suppress hepatic lipogenesis and reduce plasma lipid levels, including cholesterol and triglycerides
• Attenuate pro-inflammatory cytokine expression and modulate innate immune signaling pathways, with implications for autoimmune and metabolic disease research
• Alter the expression of circadian clock genes, affecting temporal regulation of metabolic and behavioral rhythms

⚠ Important Note: This product is supplied strictly for laboratory research use only. It is not approved for human consumption or therapeutic use. Not intended to diagnose, treat, cure, or prevent any disease.

Start your learning here: Enclomiphene Guide

Key learning: Enclomiphene Side Effects, Is Enclomiphene Legal?

Key Enclomiphene Research

• Testosterone restoration using enclomiphene citrate in men with secondary hypogonadism: a pharmacodynamic and pharmacokinetic study
• Enclomiphene citrate for the treatment of secondary male hypogonadism
• Safety and efficacy of enclomiphene and clomiphene for hypogonadal men
• Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement
• Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomised phase II clinical trial comparing topical testosterone
• Enclomiphene, an estrogen receptor antagonist for the treatment of testosterone deficiency in men